Literature DB >> 16670648

Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.

Steven R Pliszka1, Thomas L Matthews2, Kenneth J Braslow2, Melissa A Watson2.   

Abstract

OBJECTIVE: To determine whether methylphenidate (MPH) and mixed salts amphetamine (MSA) have different effects on growth in children with attention-deficit/hyperactivity disorder.
METHOD: Patients treated for at least 1 year with MPH or MSA were identified. A linear regression was performed to determine the effect of stimulant type, patient gender, cumulative stimulant dose, and length of time in treatment on change in Z scores for height. A subset of patients was identified who had 3 years of consistent stimulant treatment on either MSA or MPH. Repeated-measures analyses of variance were performed to examine the effects of time and medication type on Z scores for weight, height, and body mass index.
RESULTS: The linear regression showed no effect of stimulant type, drug holidays, or length of time of treatment on change in height Z score. Cumulative dose of stimulant had a small (-0.26) relationship to change in height Z scores. For patients treated for 3 years, there were no effects of stimulant or time on height Z scores. MSA produced more decrease in weight and body mass index Z scores than MPH; all of the subjects were heavier than average at baseline.
CONCLUSION: MSA and MPH did not differ in their effects on height. MSA had more of an effect on weight than MPH, although the effect was modest in magnitude and may be of limited clinical significance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670648     DOI: 10.1097/01.chi.0000205702.48324.fd

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  20 in total

Review 1.  Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Authors:  Benedetto Vitiello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

Review 2.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

Review 3.  A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).

Authors:  Desiree W Murray; L Eugene Arnold; Jim Swanson; Karen Wells; Karen Burns; Peter Jensen; Lily Hechtman; Natalya Paykina; Lauren Legato; Tara Strauss
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

4.  A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants.

Authors:  James G Waxmonsky; William E Pelham; Adriana Campa; Daniel A Waschbusch; Tan Li; Rebecca Marshall; Lysett Babocsai; Hugh Humphery; Elizabeth Gnagy; James Swanson; Tomasz Hanć; Negar Fallahazad; William E Pelham
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-29       Impact factor: 8.829

Review 5.  Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action.

Authors:  Steven R Pliszka
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

6.  ADHD, stimulant treatment, and growth: a longitudinal study.

Authors:  Elizabeth B Harstad; Amy L Weaver; Slavica K Katusic; Robert C Colligan; Seema Kumar; Eugenia Chan; Robert G Voigt; William J Barbaresi
Journal:  Pediatrics       Date:  2014-09-01       Impact factor: 7.124

Review 7.  Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder.

Authors:  Vanessa R Anderson; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

8.  A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD.

Authors:  Earle E Bain; Weining Robieson; Yili Pritchett; Tushar Garimella; Walid Abi-Saab; George Apostol; James J McGough; Mario D Saltarelli
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

9.  Growth effects of methylphenidate among childhood cancer survivors: a 12-month case-matched open-label study.

Authors:  Bruce W Jasper; Heather M Conklin; Joanne Lawford; E Brannon Morris; Scott C Howard; Shengjie Wu; Xiaoping Xiong; John Shelso; Raja B Khan
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

10.  Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.

Authors:  Patricia A Sirois; Grace Montepiedra; Suad Kapetanovic; Paige L Williams; Deborah A Pearson; Kathleen Malee; Patricia A Garvie; Betsy L Kammerer; Sharon L Nichols; Molly L Nozyce; Mark Mintz; Wendy G Mitchell; James M Oleske
Journal:  J Dev Behav Pediatr       Date:  2009-10       Impact factor: 2.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.